Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cambia (Royalty Interest)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A pharmaceutical product indicated for the treatment of migraine. The drug provides migraine pain relief in 2 hours with effects starting within 15 minutes from consumption.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • United States

Cambia (Royalty Interest) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Cambia (Royalty Interest)‘s full profile, request access.

Request full access to PitchBook